HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schlaudraff, K. Articles by Fasol, R. Search for Related Content PubMed PubMed Citation Articles by Schlaudraff, K. Articles by Fasol, R.

European Journal of Cardio-Thoracic Surgery, Vol 7, 637-643, Copyright © 1993 by European Association for Cardio-thoracic Surgery

ARTICLES

Growth of "new" coronary vascular structures by angiogenetic growth factors

K Schlaudraff, B Schumacher, BU von Specht, R Seitelberger, V Schlosser and R Fasol
Department of Cardiovascular Surgery, University of Freiburg, Germany.

The efficacy of the human angiogenetic heparin-binding growth factor I (HBGF-I) to initiate site-directed growth of new blood vessels from the aorta into the myocardium was studied. First, manipulated Escherichia coli bacteria, which had received the human mRNA-transcript for HBGF I into their genetic material, were cultivated. The growth factor derived was purified using heparin-Sepharose affinity chromatography. The separation and characterization of biologically active alpha- and beta- chains was carried out using high pressure liquid chromatography (HPLC) of dialyzed and lyophilized samples from the heparin-Sepharose column. One microgram HBGF I (alpha-ECGF) was bound to polytetrafluoroethylene (PTFE) sponges, precoated with collagen type I, and implanted between the aorta and the myocardium of the left ventricle in experimental rats. Twelve growth factor implants in the experimental group were compared to six controls receiving uncoated PTFE sponges for 9 weeks. Digitized computed angiography showed new blood vessels between the aorta and the myocardium in 11 of the 12 experimental animals, and retrograde coronary perfusion by these "new" vascular structures could be seen. Histology showed no specific structures in the control group (without HBGF I). In the experimental group (with HBGF I) individual vessels with highly differentiated endothelial and smooth muscle cell layers were evident. Our experiments proved the feasibility of induced, site-directed angiogenesis. It is possible to initiate in vivo growth of new "coronary" vascular structures between the aorta and the myocardium.

This article has been cited by other articles:

				M. Li, C. M. Yu, L. Cheng, M. Wang, X. Gu, K. H. Lee, T. Wang, Y. T. Sung, and J. E. Sanderson Repair of Infarcted Myocardium by an Extract of Geum japonicum with Dual Effects on Angiogenesis and Myogenesis Clin. Chem., August 1, 2006; 52(8): 1460 - 1468. [Abstract] [Full Text] [PDF]

				P. Pecher and B. A. Schumacher Angiogenesis in ischemic human myocardium: clinical results after 3 years Ann. Thorac. Surg., May 1, 2000; 69(5): 1414 - 1419. [Abstract] [Full Text] [PDF]

				J. J. Lopez, E. R. Edelman, A. Stamler, M. G. Hibberd, P. Prasad, K. A. Thomas, J. Disalvo, R. P. Caputo, J. P. Carrozza, P. S. Douglas, et al. Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H930 - H936. [Abstract] [Full Text] [PDF]

				B. Schumacher, P. Pecher, B. U. von Specht, and Th. Stegmann Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth Factors : First Clinical Results of a New Treatment of Coronary Heart Disease Circulation, February 24, 1998; 97(7): 645 - 650. [Abstract] [Full Text] [PDF]